mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |